Smoking tied to higher psoriasis risk
February 2, 2012 — NEW YORK (Reuters Health) - Adding to the list of possible health consequences from smoking, a large study suggests that smokers have an increased risk of developing the chronic skin condition psoriasis.
Heart disease more likely in people with psoriasis
January 10, 2012 — NEW YORK (Reuters Health) - People who suffer from psoriasis may want to pay extra attention to heart risks, according to a new study that found they are at a greater risk for blocked arteries than those who don't have the skin disease.
No major heart risk seen in new psoriasis drugs
August 23, 2011 — CHICAGO (Reuters) - A new, highly effective class of psoriasis drugs did not appear to raise the risk of heart problems in a review of published studies, but the analysis may not have been big enough to detect rare cases, U.S. researchers said.
Abbott psoriasis drug succeeds in pivotal trial
October 11, 2010 — NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with a commonly used medicine in a pivotal late-stage clinical trial, the company said on Monday.
Vitamin D not behind UVB's psoriasis benefit
August 17, 2010 — NEW YORK (Reuters Health) - Ultraviolet light therapy lessens the symptoms of psoriasis and simultaneously raises vitamin D levels, a new study shows. However, increased vitamin D is probably unrelated to light therapy's benefits for psoriasis, the researchers say.
Select news items provided by Reuters Health